Evidence map›Paper›PMID 34460937›Full record

Trial reportCancer2021

Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.

Ashley M Nelson, Hermioni L Amonoo, Alison R Kavanaugh, Jason A Webb, Vicki A Jackson, Julia Rice, Mitchell W Lavoie, Amir T Fathi, Andrew M Brunner, Joseph A Greer and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Palliative Care Integration in Oncology: A Review and Update.Journal of hospice and palliative care · 2025
    Review
  7. Article
  8. Updates on strategies to integrate palliative care in hematologic malignancy.Hematology. American Society of Hematology. Education Program · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Experiences of treatment decision-making among older newly diagnosed adults with acute myeloid leukemia: a qualitative descriptive study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  15. Article
  16. In their own words: a qualitative study of coping mechanisms employed by patients with acute myeloid leukemia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  17. Article
  18. Review
  19. "More than conquerors": a qualitative analysis of war metaphors for patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Ashley M NelsonMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0003-1742-3280
Hermioni L AmonooHarvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9136-9644
Alison R KavanaughMassachusetts General Hospital, Boston, Massachusetts.
Jason A WebbDuke University School of Medicine, Durham, North Carolina.ORCID 0000-0003-4048-9499
Vicki A JacksonMassachusetts General Hospital, Boston, Massachusetts.
Julia RiceMassachusetts General Hospital, Boston, Massachusetts.
Mitchell W LavoieMassachusetts General Hospital, Boston, Massachusetts.
Amir T FathiMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0003-4907-6447
Andrew M BrunnerMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-2169-4115
Joseph A GreerMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-0979-4076
Jennifer S TemelMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-7268-5921
Areej El-JawahriMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-3556-1495
Thomas W LeBlancDuke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-0546-7895
Harvard University · USMassachusetts General Hospital · USBrigham and Women's Hospital · USDuke University · USOregon Health & Science University · US

Funding

Training in Oncology Population Sciences (TOPS)T32CA092203 · NCI · DANA-FARBER CANCER INST · PI Nancy L Keating, JENNIFER W MACK · 2018 to 2026
$3.7M
A Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients.K08CA251654 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI AMONOO, HERMIONI L. · 2020 to 2024
$1.3M
NCI NIH HHS K08 CA251654NCI NIH HHS T32 CA092203
6 · The paper itself

Abstract

backgroundIt has been shown previously that integrated palliative care for patients with acute myeloid leukemia (AML) during intensive chemotherapy leads to improvements in quality of life (QOL) and mood. Coping has been shown to mediate palliative care interventions in advanced cancer; the mechanisms by which improvements occur among patients with AML remain unexplained.

methodsThe authors conducted a secondary analysis of data from a multisite randomized trial of integrated palliative and oncology care (IPC; n = 86) versus usual care (n = 74) for hospitalized patients with AML undergoing intensive chemotherapy. IPC patients met with palliative care at least twice weekly during their initial and subsequent hospitalizations. Patients completed the Functional Assessment of Cancer Therapy-Leukemia, the Hospital Anxiety and Depression Scale, and the Brief Coping Orientation to Problems Experienced Inventory to assess QOL, mood, and coping at the baseline and at weeks 2, 4, 12, and 24. Linear regression models were used to assess the effect of IPC on coping. Causal mediation regression models were used to examine whether changes in coping mediated intervention effects on patient-reported outcomes at week 2.

resultsOne hundred sixty eligible patients (68.1%) were enrolled. Those randomized to IPC reported improvements in approach-oriented coping (P < .01) and reductions in avoidant coping (P < .05). These changes in coping mediated the intervention effects on QOL (95% CI, 2.14-13.63), depression (95% CI, -2.05 to -0.27), and anxiety symptoms (95% CI, -1.25 to -0.04). Changes in approach-oriented and avoidant coping accounted for 78% of the total palliative care intervention effect on QOL, for 66% of the effect on depression, and for 35% of the effect on anxiety symptoms.

conclusionsPalliative care integrated during intensive chemotherapy for patients with AML facilitates coping strategy use. Improvement in coping skills accounts for a substantial proportion of the effect from a palliative care intervention on patient-reported outcomes.

Indexed as

Leukemia, Myeloid, AcuteQuality of LifeAdaptation, PsychologicalDepressionHumansMediation AnalysisPalliative Careacute myeloid leukemia (AML)copingdistresspalliative care interventionquality of life

Identifiers

PMID34460937
PMCPMC8664993
OpenAlexW3198632248

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.